NCT06275945View on ClinicalTrials.gov

Feasibility Study of A VoRo UrologIc ScaffolD (ARID)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

July 30, 2026

Study Completion Date

October 30, 2026

Conditions
Stress Urinary IncontinenceRadical Prostatectomy
Interventions
DEVICE

Voro Urologic Scaffold

radical prostatectomy

Trial Locations (1)

Unknown

National Hospital, Panama City

Sponsors

Collaborators (1)

RQM+
All Listed Sponsors
collaborator

RQM+

INDUSTRY

lead

Levee Medical, Inc.

INDUSTRY

NCT06275945 - Feasibility Study of A VoRo UrologIc ScaffolD (ARID) | Biotech Hunter | Biotech Hunter